晚期癌症老年患者临终住院期间重症监护使用趋势
该研究利用SEER-Medicare数据(2003-2017)分析晚期实体癌老年医保受益人临终住院期间ICU、生命维持治疗(LST)和无创通气(NIV)的使用趋势。共纳入226,263例,61.1%在临终期住院,住院率总体稳定但ICU、LST和NIV使用强度上升,院内死亡者接受ICU比例从46.5%升至65.0%。
要点
- 临终住院率保持高位,2017年为75.5%。
- 无ICU的临终住院比例下降,ICU联合LST或NIV的住院比例上升。
- 院内死亡者接受ICU照护的比例从46.5%增至65.0%。
核心结论
- 晚期癌症老年患者临终住院率在2004-2017年间保持稳定,但临终住院期间重症监护强度增加。
研究设计与样本
- 基于SEER-Medicare数据(2003-2017)的回顾性队列研究,纳入诊断后3年内死亡的晚期实体癌(summary stage 7)医保受益人226,263例。
主要发现
- 临终住院率从2004年78.1%(95% CI: 77.4, 78.7)降至2017年75.5%(95% CI: 74.5, 76.2)。
- 无ICU的临终住院从49.3%(95% CI: 48.5, 50.2)降至35.0%(95% CI: 34.2, 35.9)。
- 有ICU无LST或NIV的临终住院从23.7%(95% CI: 23.0, 24.4)升至28.7%(95% CI: 27.9, 29.5)。
- 有ICU和NIV但无LST的临终住院从0.8%(95% CI: 0.6, 0.9)升至3.8%(95% CI: 3.4, 4.1)。
- 有ICU和LST的临终住院从4.3%(95% CI: 4.0, 4.7)升至8.0%(95% CI: 7.5, 8.5)。
关键数值与推荐
- 临终住院定义为死亡前30天内住院,按照护强度分为无ICU、有ICU无LST或NIV、有ICU和NIV无LST、有ICU和LST四类。
- LST包括有创机械通气、气管切开、胃造瘘、急性透析。
- 院内死亡者接受ICU照护的比例从46.5%增至65.0%。
临床怎么用
- 老年医学科医生应关注晚期癌症患者临终照护强度上升趋势,在共享决策中结合患者偏好讨论ICU、LST和NIV的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-intensity end-of-life (EOL) care, marked by admission to intensive care units (ICUs) or in-hospital death, can be costly and burdensome. Recent trends in use of ICUs, life-sustaining treatments (LSTs), and noninvasive ventilation (NIV) during EOL hospitalizations among older adults with advanced cancer and patterns of in-hospital death are unknown. METHODS: We used SEER-Medicare data (2003-2017) to identify beneficiaries with advanced solid cancer (summary stage 7) who died within 3 years of diagnosis. We identified EOL hospitalizations (within 30 days of death), classifying them by increasing intensity of care into: (1) without ICU; (2) with ICU but without LST (invasive mechanical ventilation, tracheostomy, gastrostomy, acute dialysis) or NIV; (3) with ICU and NIV but without LST; and (4) with ICU and LST use. We constructed a multinomial regression model to evaluate trends in risk-adjusted hospitalization, overall and across hospitalization categories, adjusting for sociodemographics, cancer characteristics, comorbidities, and frailty. We evaluated trends in in-hospital death across categories. RESULTS: Of 226,263 Medicare beneficiaries with advanced cancer, 138,305 (61.1%) were hospitalized at EOL [Age, Mean (SD):77.9(7.1) years; 45.5% female]. Overall, EOL hospitalizations remained high throughout, from 78.1% (95% CI: 77.4, 78.7) in 2004 to 75.5% (95% CI: 74.5, 76.2) in 2017. Hospitalizations without ICU use decreased from 49.3% (95% CI: 48.5, 50.2) to 35.0% (95% CI: 34.2, 35.9) while hospitalizations with more intensive care increased, from 23.7% (95% CI: 23.0, 24.4) to 28.7% (95% CI: 27.9, 29.5) for ICU without LST or NIV, 0.8% (95% CI: 0.6, 0.9) to 3.8% (95% CI: 3.4, 4.1) for ICU with NIV but without LST, and 4.3% (95% CI: 4.0, 4.7) to 8.0% (95% CI: 7.5, 8.5) for ICU with LST use. Among those who experienced in-hospital death, the proportion receiving ICU care increased from 46.5% to 65.0%. CONCLUSIONS: Among older adults with advanced cancer, EOL hospitalization rates remained stable from 2004-2017. However, intensity of care during EOL hospitalizations increased as evidenced by increasing use of ICUs, LSTs, and NIV.
引用
- Jain S, Long JB, Rao V, et al. Trends in use of intensive care during hospitalizations at the end-of-life among older adults with advanced cancer. J Am Geriatr Soc. 2024. PMID: 39090970. doi:10.1111/jgs.19119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。